These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 7587422

  • 21. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response.
    Bhagat R, Swystun VA, Cockcroft DW.
    J Allergy Clin Immunol; 1996 Jan; 97(1 Pt 1):47-52. PubMed ID: 8568137
    [Abstract] [Full Text] [Related]

  • 22. Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study.
    Wilding P, Clark M, Thompson Coon J, Lewis S, Rushton L, Bennett J, Oborne J, Cooper S, Tattersfield AE.
    BMJ; 1997 May 17; 314(7092):1441-6. PubMed ID: 9167559
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.
    Simons FE, Gerstner TV, Cheang MS.
    Pediatrics; 1997 May 17; 99(5):655-9. PubMed ID: 9113940
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
    Gong H, Linn WS, Shamoo DA, Anderson KR, Nugent CA, Clark KW, Lin AE.
    Chest; 1996 Nov 17; 110(5):1229-35. PubMed ID: 8915226
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
    Giannini D, Di Franco A, Bacci E, Dente FL, Taccola M, Vagaggini B, Paggiaro P.
    Chest; 2000 May 17; 117(5):1319-23. PubMed ID: 10807817
    [Abstract] [Full Text] [Related]

  • 29. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.
    Boulet LP, Laviolette M, Boucher S, Knight A, Hébert J, Chapman KR.
    J Allergy Clin Immunol; 1997 Jan 17; 99(1 Pt 1):13-21. PubMed ID: 9003206
    [Abstract] [Full Text] [Related]

  • 30. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma.
    Kraft M, Wenzel SE, Bettinger CM, Martin RJ.
    Chest; 1997 May 17; 111(5):1249-54. PubMed ID: 9149578
    [Abstract] [Full Text] [Related]

  • 31. Tolerance to the protective effect of salmeterol on allergen challenge.
    Giannini D, Carletti A, Dente FL, Bacci E, Di Franco A, Vagaggini B, Paggiaro PL.
    Chest; 1996 Dec 17; 110(6):1452-7. PubMed ID: 8989060
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
    Lee DK, Jackson CM, Bates CE, Lipworth BJ.
    Thorax; 2004 Aug 17; 59(8):662-7. PubMed ID: 15282385
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.
    Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske RF, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E, National Heart, Lung and Blood Institute's Asthma Clinical Research Network.
    Lancet; 2009 Nov 21; 374(9703):1754-64. PubMed ID: 19932356
    [Abstract] [Full Text] [Related]

  • 37. Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge.
    Giannini D, Bacci E, Dente FL, Di Franco A, Vagaggini B, Testi R, Paggiaro P.
    Chest; 1999 Mar 21; 115(3):629-34. PubMed ID: 10084467
    [Abstract] [Full Text] [Related]

  • 38. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma.
    Taylor DA, Jensen MW, Aikman SL, Harris JG, Barnes PJ, O'Connor BJ.
    Am J Respir Crit Care Med; 1997 Dec 21; 156(6):1731-7. PubMed ID: 9412548
    [Abstract] [Full Text] [Related]

  • 39. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
    Fitzpatrick MF, Mackay T, Driver H, Douglas NJ.
    BMJ; 1990 Dec 15; 301(6765):1365-8. PubMed ID: 1980220
    [Abstract] [Full Text] [Related]

  • 40. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction.
    Boulet LP, Turcotte H, Cartier A, Milot J, Côté J, Malo JL, Laviolette M.
    Chest; 1998 Aug 15; 114(2):373-9. PubMed ID: 9726717
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.